Noninvasive Cervical Electrical Stimulation for ALS: Mechanistic and Safety Study
Veterans are at higher risk than non-Veterans of falling ill with amyotrophic lateral sclerosis (ALS). ALS causes degeneration of motor neurons in both the brain and the spinal cord. Evidence from studies in people with spinal cord injury suggests that activating spared nerve circuits with electromagnetic stimulation improves nerve transmission.
With this goal, the investigators have developed a novel method of noninvasive cervical (neck) electrical stimulation (CES). In this study, the investigators will investigate CES for its potential to strengthen nerve circuits to the hands in ALS.
To the investigators' knowledge, electrical spinal stimulation for ALS has never been tested previously. This study will be performed in two stages: First, basic experiments will be performed to better understand how CES interacts with other types of electrical and magnetic stimulations over the brain and peripheral nerves. Second, experiments will be performed to determine the types of CES that can facilitate active arm and hand movements.
These experiments will improve understanding of electrical stimulation in ALS, and may set the table for future treatments.
Both United States Veterans and non-Veterans are eligible to participate in this study.
Disease:Amyotrophic Lateral Sclerosis (ALS), Familial ALS, Sporadic ALS
Study Type:Interventional Trial
Study Chair(s)/Principal Investigator(s):
Noam Y. Harel, MDm PhD, VA Office of Research and Development
Clinicaltrials.gov ID (11 digit #):NCT03411863
Coordinating Center Contact Information
Bronx, New York 10468 United States
Full Study Summary:
Amyotrophic lateral sclerosis (ALS) reduces connections between the cortical motor neurons that initiate movement and the spinal motor neurons that direct muscles to execute movement. This situation shares many key features with incomplete spinal cord injury (SCI). Accumulating evidence in SCI suggests that externally activating spared nerve circuits with electromagnetic stimulation augments neural transmission.
With this goal, the investigators developed a novel method of noninvasive cervical electrical stimulation (CES). CES activates multiple muscles on both upper limbs by triggering afferent sensory or efferent motor nerve roots depending on stimulus intensity. This study will investigate CES for its potential to strengthen residual circuits to the hands in ALS.
To the investigators' knowledge, electrical spinal stimulation for ALS has never been tested or applied previously. Therefore, a pilot study is essential. This study will be performed in two stages:
Map CES circuit and synaptic targets: The experiments share a common structure comprising conditioning and test stimuli delivered at a range of intensities, sites, and interstimulus intervals.
Determine parameters for combining CES with volitional movement: volitional limb movements depend on the same corticospinal and motor neuron circuits as those activated by TMS and F-waves. Since preliminary data shows that subthreshold CES facilitates TMS responses, CES may also be able to facilitate volitional limb movements.
Successful completion of these experiments will: mechanistically elucidate CES circuit interactions; investigate the potential for CES to enhance concurrent volitional muscle activation; and establish CES as safe and feasible in the ALS population. Given the limited treatment options for ALS, any amount of progress would represent a meaningful step forward. Moreover, results of this pilot study could lead to direct translation for lasting clinical benefit by combining repetitive subthreshold CES with repetitive task-oriented physical exercise training in subsequent studies. CES would be compatible with other interventions, including medications and cell-based treatments.
Study Sponsor:VA Office of Research and Development
Estimated Study Start Date:01/04/2018
Estimated Study Completion Date:05/31/2021
Posting Last Modified Date:10/15/2020
Date Study Added to alsconsortium.org:05/29/2018
Time since Symptom Onset:N/A
Time since Diagnosis:N/A
Can participants use Riluzole?Yes
Age between 21 and 65 years
Diagnosis of probable or definite ALS (or non-disabled volunteer)
Incomplete weakness of left or right wrist or hand muscles:
- score of 2, 3, or 4 (out of 5) on manual muscle testing of wrist extension
- wrist flexion
- finger extension
- finger flexion
- or finger abduction
Detectable F-wave responses of the left or right APB to median nerve stimulation and/or ADM to ulnar nerve stimulation
US Veteran or non-Veteran
History of other serious injury or disease of central or peripheral nervous system
History of seizures
Ventilator dependence or patent tracheostomy site
Use of medications that significantly lower seizure threshold
History of head trauma with evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging
History of implanted:
- brain/spine/nerve stimulators
- aneurysm clips
- ferromagnetic metallic implants
- or cardiac pacemaker/defibrillator
Significant coronary artery or cardiac conduction disease
History of bipolar disorder or suicide attempt or active psychosis
Heavy alcohol consumption (> equivalent of 5 oz of liquor) within previous 48 hours
Open skin lesions over the face, neck, shoulders, or arms
Unsuitable for study participation as determined by study physician
- Site Contact Information